about
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hyperte...
Read More
12.78
0.33
(2.65%)
2.7M
XNAS Volume
XNAS 08 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Liquidia Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..